Stockreport

Repare Therapeutics Announces New Data Underscoring Need for Additional Treatment Solutions for Patients with Metastatic Gynecologic Cancers [Yahoo! Finance]

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF and endometrial cancers with CCNE1 amplifications, FBXW7 or PP2R1A mutations carry poor prognosis Significant survival disparities were identified in patients harborin [Read more]